Would the initially observed benefits of surgery stand the test of time? According to findings from a three-year follow-up study to STAMPEDE, also recently published in NEJM, the answer is yes. The STAMPEDE trial investigators analyzed glycated hemoglobin levels to see how well glycemic control was maintained after three years.